Papers/PMID:27317162
Effects of L-carnitine supplementation on lipid profiles in patients with coronary artery disease.
Lipids in health and disease2016The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
(R)-carnitine — increases HDL cholesterol
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Finding“The subjects in the LC group had significantly higher level of HDL-C (1.34 ± 0.42 vs. 1.16 ± 0.24 mmol/L, P = 0.03) and Apo-A1 (1.24 ± 0.18 vs. 1.12 ± 0.13 g/L, P = 0.02) than those in the placebo group at week 12.”
Quoted verbatim from Effects of L-carnitine supplementation on lipid profiles in patients with coronary artery disease.. - Study
- RCT
- Duration
- 3 months
- Dose
- 1000 mg/day L-carnitine as 500 mg twice daily for 12 weeks
- Population
- Male patients with coronary artery disease (at least 50% stenosis of a major coronary artery), 39 completers, week 12 values compared with starch placebo; single-blind
Effects of L-carnitine supplementation on lipid profiles in patients with coronary artery disease.2016PMID:27317162Permalink